Arformoterol Tartrate

Pharm Company: * TEVA PHARMS USA
Category: Lungs (Pulmonary)

* This drug may consist of multiple approval dates, manufacturers, or distributors. If applicable, they would be listed below under "NDC Database Records".

Arformoterol Tartrate Overview

Arformoterol is a long-acting β2 adrenoreceptor agonist (LABA) indicated for the treatment of chronic obstructive pulmonary disease (COPD). It is sold by Sunovion, under the trade name Brovana, as a solution of arformoterol tartrate to be administered twice daily (morning and evening) by nebulization.[1] It is the active (R,R)-(−)-enantiomer of formoterol and was approved by the United States Food and Drug Administration (FDA) on October 6, 2006, for the treatment o...

Read more Arformoterol Tartrate Details
Details May Include Instructions, Side Effects, Interactions, Etc. Drug monograph is from Wikipedia. All text is available under the terms of the GFDL (GNU Free Documentation License). Source: en.wikipedia.org/wiki/Arformoterol

Recent Arformoterol Tartrate Forums:

Be the first to start a discussion about this drug.

Possible Dosages for this and Related Drugs:

Arformoterol Tartrate

Solution: 0.015mg/2ml, 15mcg(base)/2ml, 15mcg/ml
Unknown: Unknown

Note: Above list includes dosages for all drugs with the same combination of active ingredients.

NDC Database Records for Arformoterol Tartrate: (4 results)

Sorted by National Drug Code

68462-833 Arformoterol Tartrate 15 ug/2ml Respiratory (Inhalation) Solution by Glenmark Pharmaceuticals Inc., USA
69097-168 Arformoterol Tartrate 15 ug/2ml Respiratory (Inhalation) Solution by Cipla USA Inc.
70436-151 Arformoterol Tartrate Inhalation Inhalation 15 ug/2ml Respiratory (Inhalation) Solution by Slate Run Pharmaceuticals
70748-257 Arformoterol Tartrate 15 ug/2ml Respiratory (Inhalation) Solution by Lupin Pharmaceuticals, Inc.

Other drugs which contain Arformoterol Tartrate or a similar ingredient: (1 result)

BROVANA Arformoterol Tartrate1 discussion